You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb2950002 |
|---|---|
| Category | Antibodies |
| Description | REGN5093-M114 is a bispecific antibody-drug conjugate (ADC) that targets two epitopes of the MET receptor tyrosine kinase, effectively inhibiting NSCLC cell proliferation and demonstrating antitumor activity in mouse models. REGN5093-M114 is composed of the human monoclonal anti-MET antibody Davutamig and a tubulin-inhibiting linker-payload. |
| Target | Microtubule Associated,Antibody-Drug Conjugates (ADCs),c-Met/HGFR |
| Clonality | Recombinant |
| Conjugation | Unconjugated |
| Antibody Type | Inhibitor Antibody |
| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
| Research Area | Signal Transduction |
| Note | For research use only |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review